Transthyretin-related Cardiac Amyloidosis
📧 Sign up to get email alerts when something new happens for Transthyretin-related Cardiac Amyloidosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-11-19Clinical Trial Update: Screening for Cardiac Amyloidosis With Nuclear Imaging for Minority Populations
Clinical trial update reporting completion of a study on nuclear imaging screening for transthyretin-related cardiac amyloidosis in minority…
-
CLINICAL_TRIALS research · 2025-10-23Clinical Trial Update: N-of-1 for Beta-Blockers in Cardiac Amyloidosis [Phase 4]
An N-of-1 trial evaluating beta-blockers for cardiac amyloidosis is currently enrolling by invitation in Phase 4.
-
CLINICAL_TRIALS trial_result · 2018-06-15Clinical Trial Update: A Extension Study to Evaluate Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Cardiac Amyloidosis [Phase 2]
Phase 2 extension study evaluating Revusiran (ALN-TTRSC) in transthyretin cardiac amyloidosis has completed with posted results.